An S1P antagonist FTY720/fingolimod has also been shown to alleviate the symptoms of murine MAFLD and NASH by inhibiting pro-inflammatory macrophage chemotaxis. The gene discussed is MBTPS1; the disease is metabolic dysfunction-associated steatohepatitis.